aid: flowneuroscience
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/flowneuroscience.png
name: Flowneuroscience
description: 'Flow Neuroscience is a Malmo, Sweden medtech company founded in 2016
  by clinical psychologist Daniel Mansson and neuroscientist Erik Rehn. It develops
  a medically approved, at-home transcranial direct current stimulation (tDCS) headset
  paired with a behavioral-therapy smartphone app to treat major depressive disorder
  without medication. Its Flow FL-100 device is CE-marked in the EU and UK and received
  FDA approval (PMA P230024) as the first at-home tDCS treatment for depression, with
  a US launch planned for September 2026. Flow is backed by Khosla Ventures and other
  global investors. This is a consumer and clinical medical-device company; no public
  developer API, OpenAPI, or developer portal was found during enrichment.'
url: https://raw.githubusercontent.com/api-evangelist/flowneuroscience/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- khosla-ventures
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-19'
tags:
- Company
- Health
- Healthcare
- Medical Devices
- Mental Health
- Depression
- Neuroscience
- Neurotechnology
- Digital Health
- Medtech
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/flowneuroscience-domain-security.yml
- type: Website
  url: https://www.flowneuroscience.us/
- type: SignUp
  url: https://www.flowneuroscience.us/patient-sign-up?hsLang=en-us
- type: Login
  url: https://hcp.flowneuroscience.com/
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence